Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Revenue (Annual): 108.78M for Dec. 31, 2022
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2022 | 108.78M |
| December 31, 2021 | 69.86M |
| December 31, 2020 | 132.30M |
| December 31, 2019 | 82.27M |
| December 31, 2018 | 53.45M |
| December 31, 2017 | 115.45M |
| December 31, 2016 | 21.51M |
| June 30, 2016 | 60.00M |
| June 30, 2015 | 85.54M |
| June 30, 2014 | 59.90M |
| June 30, 2013 | 35.54M |
| June 30, 2012 | 16.36M |
| June 30, 2011 | 19.30M |
| June 30, 2010 | 13.94M |
| June 30, 2009 | 27.99M |
| June 30, 2008 | 40.25M |
| June 30, 2007 | 38.21M |
| June 30, 2006 | 32.09M |
| Date | Value |
|---|---|
| June 30, 2005 | 35.72M |
| June 30, 2004 | 25.96M |
| June 30, 2003 | 7.628M |
| June 30, 2002 | 5.883M |
| June 30, 2001 | 4.479M |
| June 30, 2000 | 11.18M |
| June 30, 1999 | 3.70M |
| June 30, 1998 | 0.50M |
| June 30, 1997 | 0.60M |
| June 30, 1996 | 0.60M |
| June 30, 1995 | 0.50M |
| June 30, 1994 | 0.90M |
| June 30, 1993 | 1.70M |
| June 30, 1992 | 2.70M |
| June 30, 1991 | 3.40M |
| June 30, 1990 | 1.00M |
| June 30, 1989 | 0.80M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
69.86M
Minimum
2021
132.30M
Maximum
2020
98.30M
Average
95.53M
Median
Revenue (Annual) Benchmarks
| AbbVie Inc | 54.32B |
| Pfizer Inc | 58.50B |
| Johnson & Johnson | 85.16B |
| Merck & Co Inc | 60.12B |
| Cerevel Therapeutics Holdings Inc | -- |